Autopsy report · NCT01441284

Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor

“Lack of financial support”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

University of Pecs

Sponsor type

University, hospital or other

Conditions

Essential Tremor

Interventions

pramipexole; placebo

Participants

0

Sites

2

Countries

Hungary

Trials that died the same way

• Impact of Surgical Theater's Patient Engagement
  “Lack of support/funding” (86% match in meaning)
• Treatment of Covid-19 Infections Using Vitality Therapy or the Bible Cure
  “No Financial Support” (86% match in meaning)
• Effects of Empowerment-based Program on Post-discharge Glycemic Control, and Foot Ulcer
  “Lack of financial resources” (82% match in meaning)
• Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer
  “No financial support aproved” (80% match in meaning)
• Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
  “Lack of financial support and low inclusion rate” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.